TDP-43 loss of function drives aberrant splicing in Parkinson's disease www.biorxiv.org/content/10.1101/2025.09....

Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson's disease Parkinson's disease (PD) is characterised by insoluble α-synuclein (αSyn) aggregates in Lewy bodies (LBs) within the substantia nigra, with cortical pathology appearing as the disease progresses. Late...

Out now on biorxiv! Excited to share our latest collaborative work investigating the earliest stages of Parkinson’s disease.

www.biorxiv.org/content/10.1...

Thanks to all the amazing co-authors Melissa Grant-Peters @jsbeckwith.bsky.social @stevethechemist.bsky.social Mina Ryten Sonia Gandhi

Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson's disease www.biorxiv.org/content/10.1101/2025.08....